CLINICAL_TRIALS
trial_result
· 2022-10-31
Clinical Trial Update: Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging [Phase 1, Phase 2]
Summary
A safety study evaluating bone marrow-derived stem cells for treating photoaged skin has been conducted in Phase 1/2, with unknown current status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stemedica Cell Technologies, Inc. | Conditions: Chronic Effect of Ultraviolet Radiation on Photoaged Skin, Dermatologic Disorders | Phase 1, Phase 2 | Status: UNKNOWN